IBB ETF holdings (NASDAQ) - Page 3 | MetaTrader

Abrir gráfico completo

Visão geral Todos os ativos Mapa de calor

Principais ativos Market Value Shares Weight %

RYTM Rhythm Pharmaceuticals, Inc. 41.3 M 474.5 K 0.5%

ABVX Abivax SA 40.9 M 367.5 K 0.5%

PTCT PTC Therapeutics, Inc. 40.4 M 593.2 K 0.5%

COGT Cogent Biosciences, Inc. 38.9 M 1.0 M 0.5%

A

ACLX Arcellx, Inc. 38.6 M 335.8 K 0.5%

Terns Pharmaceuticals, Inc. 37.6 M 713.8 K 0.5%

NUVL Nuvalent, Inc. 36.4 M 355.5 K 0.4%

MIRM Mirum Pharmaceuticals, Inc. 36.3 M 392.7 K 0.4%

TEM Tempus AI, Inc. 35.0 M 773.9 K 0.4%

XENE Xenon Pharmaceuticals, Inc. 34.8 M 598.4 K 0.4%

F

FOLD Amicus Therapeutics, Inc. 33.4 M 2.3 M 0.4%

CRSP CRISPR Therapeutics AG 31.6 M 663.7 K 0.4%

Apellis Pharmaceuticals, Inc. 31.3 M 778.2 K 0.4%

APGE Apogee Therapeutics, Inc. 29.8 M 353.5 K 0.4%

SRRK Scholar Rock Holding Corp. 29.2 M 593.7 K 0.4%

ACAD ACADIA Pharmaceuticals, Inc. 27.9 M 1.3 M 0.3%

BRKR Bruker Corp. 27.6 M 764.3 K 0.3%

CRNX Crinetics Pharmaceuticals, Inc. 26.4 M 726.4 K 0.3%

CGON CG oncology, Inc. 25.7 M 379.3 K 0.3%

SYRE Spyre Therapeutics, Inc. 24.2 M 478.9 K 0.3%

1
2
3
4
5
6
7
8
...
13

Notícias

UBS lista 5 motivos principais pelos quais ações de biotecnologia de médio porte devem se destacar em 2026